| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.78M | - | |
| CEO | 338.1K | $2.58M | - | |
| Other | 240.7K | $1.84M | - | |
| Other | 240.3K | $1.83M | - | |
| CFO | 147.1K | $1.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Patrick J. Christmas | SVP, General Counsel | Sale+OE | 5,000 | $47.54 | $237,697.90 | -65.2% | |
| Dec 17, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 15,000 | $46.73 | $700,926.64 | -6.5% | |
| Dec 17, 2018 | Vittal Vasista79 | Chief Financial Officer | Sell | 7,500 | $46.35 | $347,650.00 | -5.8% | |
| Dec 3, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 20,000 | $60.40 | $1,208,087.00 | -8.0% | |
| Dec 3, 2018 | Stephen Yoo | Chief Medical Officer | Sale+OE | 20,414 | $60.13 | $1,227,412.43 | - | |
| Nov 29, 2018 | Luke M Beshar | Director | Sale+OE | 12,784 | $65.00 | $830,960.00 | - | |
| Nov 27, 2018 | Luke M Beshar | Director | Sale+OE | 20,507 | $65.03 | $1,333,518.58 | - | |
| Nov 26, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 20,000 | $64.17 | $1,283,354.60 | -7.4% | |
| Nov 21, 2018 | Kenneth T. Mills81 | President and CEO | Sell | 15,000 | $61.44 | $921,659.60 | -5.2% | |
| Nov 20, 2018 | Luke M Beshar | Director | Sale+OE | 33,292 | $60.44 | $2,012,209.04 | - |